The USPTO issued Patent US12594006B2 to Wavely Diagnostic Inc., covering a system and method for remote detection of otitis media in children. The invention comprises a smartphone application with a pop-open soundwave guide that directs audio signals from the phone's speaker to the patient's eardrum and returns acoustic data to the phone's microphone for analysis. The patent names four inventors and covers CPC classifications including A61B 5/125 (measuring for diagnostic purposes), A61B 5/6817 (phone-based sensors), and G16H 50/20 (ICT for diagnosis).\n\nCompetitors developing similar smartphone-based otitis media detection applications or telemedicine diagnostic tools should review the patent claims (5 total) to assess potential infringement risks. While patent grants do not impose regulatory compliance deadlines, companies in the digital health, telehealth, or mobile medical device space should consider this IP landscape when designing similar products. The patent provides Wavely Diagnostic with exclusionary rights in the US for the claimed diagnostic method and system.